Chemfab Alkalis Limited (NSE:CHEMFAB)
India · Delayed Price · Currency is INR 405.30
-0.60 (-0.15%)
Jun 3, 2026, 3:25 PM IST
Chemfab Alkalis Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,110 | 3,344 | 3,273 | 3,314 | 2,716 | |
Revenue Growth (YoY) | -6.98% | 2.16% | -1.23% | 22.01% | 50.21% |
Cost of Revenue | 2,153 | 2,245 | 2,139 | 1,709 | 1,730 |
Gross Profit | 957.46 | 1,099 | 1,133 | 1,605 | 986.29 |
Selling, General & Admin | 263.22 | 262.23 | 236.26 | 194.76 | 198.62 |
Other Operating Expenses | 422.06 | 392.64 | 359.4 | 303.41 | 209.58 |
Operating Expenses | 969.47 | 1,018 | 819.16 | 727.48 | 630.41 |
Operating Income | -12.01 | 81.03 | 314.32 | 877.09 | 355.89 |
Interest Expense | -76.87 | -49.25 | -9.42 | -2.45 | -10.13 |
Interest & Investment Income | - | 4.21 | 20.72 | 6.23 | 17.2 |
Currency Exchange Gain (Loss) | - | - | 1.12 | 0.67 | 0.42 |
Other Non Operating Income (Expenses) | 86.88 | 35.1 | 15.46 | 17.3 | 30.28 |
EBT Excluding Unusual Items | -2 | 71.09 | 342.2 | 898.83 | 393.66 |
Gain (Loss) on Sale of Investments | - | 2.08 | 31.1 | 29.24 | 6.48 |
Gain (Loss) on Sale of Assets | - | 6.28 | 2.66 | 2.15 | -10.36 |
Asset Writedown | - | - | - | -2.38 | - |
Other Unusual Items | - | -82.51 | 15.51 | -33.46 | 1.25 |
Pretax Income | -2 | -3.05 | 391.47 | 894.39 | 391.02 |
Income Tax Expense | 32.27 | 66.35 | 128.23 | 248.55 | 103.55 |
Net Income | -34.27 | -69.4 | 263.23 | 645.83 | 287.47 |
Net Income to Common | -34.27 | -69.4 | 263.23 | 645.83 | 287.47 |
Net Income Growth | - | - | -59.24% | 124.66% | - |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 |
Shares Change (YoY) | 0.76% | -0.43% | 0.31% | 0.53% | 1.59% |
EPS (Basic) | -2.38 | -4.86 | 18.53 | 45.61 | 20.36 |
EPS (Diluted) | -2.38 | -4.86 | 18.34 | 45.14 | 20.20 |
EPS Growth | - | - | -59.37% | 123.47% | - |
Free Cash Flow | -531.25 | -734.81 | -605.69 | 349.83 | 347.14 |
Free Cash Flow Per Share | -36.90 | -51.43 | -42.21 | 24.45 | 24.39 |
Dividend Per Share | 1.250 | 1.250 | 1.250 | 1.250 | 1.250 |
Gross Margin | 30.78% | 32.87% | 34.63% | 48.42% | 36.32% |
Operating Margin | -0.39% | 2.42% | 9.60% | 26.47% | 13.10% |
Profit Margin | -1.10% | -2.08% | 8.04% | 19.49% | 10.59% |
Free Cash Flow Margin | -17.08% | -21.98% | -18.51% | 10.56% | 12.78% |
EBITDA | 272.18 | 437.47 | 531.58 | 1,100 | 574 |
EBITDA Margin | 8.75% | 13.08% | 16.24% | 33.21% | 21.14% |
D&A For EBITDA | 284.2 | 356.44 | 217.27 | 223.37 | 218.12 |
EBIT | -12.01 | 81.03 | 314.32 | 877.09 | 355.89 |
EBIT Margin | -0.39% | 2.42% | 9.60% | 26.47% | 13.10% |
Effective Tax Rate | - | - | 32.76% | 27.79% | 26.48% |
Revenue as Reported | 3,197 | 3,415 | 3,358 | 3,369 | 2,773 |
Advertising Expenses | - | 3.27 | 0.94 | 1.25 | 1.44 |